To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.
Clinical trial NCT03658213 · WITHDRAWN
Trial details
- NCT number
- NCT03658213
- Sponsor
- AstraZeneca
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-31
- Primary completion
- 2021-11-04
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.